ClinicalTrials.gov
ClinicalTrials.gov Menu

PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02867332
Recruitment Status : Not yet recruiting
First Posted : August 15, 2016
Last Update Posted : August 15, 2016
Sponsor:
Collaborator:
Cell Biotech Co., Ltd.
Information provided by (Responsible Party):
Yinglu Guo, Peking University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : November 2020
  Estimated Study Completion Date : November 2020
Publications of Results:
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):